SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.826-0.5%Nov 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Caradonna who wrote (702)5/8/1996 9:35:00 AM
From: bill small   of 14328
 
Peter, some info on TRIBY capacity and market

TRIBY has researched the market size now and projections in out years.
They estimate the clinical lab market at $15B now growing to $18B by
year 2000. Of greater significance, the particular market they are
targeting is the point of care and over the counter (POC/OTC) which
is $1B today growing to $5B by year 2000. As you can see their
market has explosive growth projections. This growth is so great
for a number of reasons but I think some primary ones include cost
containment and greater availability of reliable test which are
becoming available now (eg the TRIBY products). The race is on to
capture market share and TRIBY is racing ahead in my view.

Regards production capacity, TRIBY can produce about one million
per year (this is from my memory, may not be precise) BUT can EASILY
expand their current plant capacity. This info is from company.
This isn't a concern because the product production could even be
outsourced if necessary.

Hope this all understand the potential of our company.

best to all.........Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext